|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to the prescription of a controlled substance to certain |
|
patients for the treatment of pain. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Subchapter C, Chapter 481, Health and Safety |
|
Code, is amended by adding Section 481.0725 to read as follows: |
|
Sec. 481.0725. PRESCRIPTION OF CONTROLLED SUBSTANCE AFTER |
|
DRUG TEST. A practitioner may not refuse to prescribe a controlled |
|
substance for the treatment of pain to a patient solely because the |
|
results of a drug test taken by the patient indicated that |
|
tetrahydrocannabinol or cannabidiol was present in the patient's |
|
body, or refuse to continue to treat the patient. |
|
SECTION 2. The change in law made by this Act applies only |
|
to a prescription issued on or after the effective date of this Act. |
|
|
|
A prescription issued before the effective date of this Act is |
|
governed by the law in effect on the date the prescription is |
|
issued, and the former law is continued in effect for that purpose. |
|
SECTION 3. This Act takes effect September 1, 2019. |